CAPR - Chief Financial Officer at Capricor Therapeutics Exercises Options Worth $6K | Benzinga
Anthony Bergmann, Chief Financial Officer at Capricor Therapeutics (NASDAQ:CAPR), reported a large exercise of company stock options on October 24, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Bergmann, Chief Financial Officer at Capricor Therapeutics, a company in the Health Care sector, just exercised stock options worth 2,178 shares of CAPR stock with an exercise price of $1.39.
Capricor Therapeutics shares are trading up 1.28% at $2.78 at the time of this writing on Wednesday morning. Since the current price is $2.78, this makes Bergmann's 2,178 shares worth $6,054.